SIRS-Lab announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compare ... more
Board elects new CEO to molecular diagnostics company SIRS-Lab GmbH
08-10-2009: SIRS-Lab GmbH has elected Barbara Staehelin as new Chief Executive Officer. Swiss national Barbara Staehelin is a biochemist and holds an MBA from INSEAD (Fontainebleau). She is a life science entrepreneur and has also made a career in the diagnostics industry. Until 2006, she was a member of the Global Executive Committee of Roche Diagnostics.
Barbara Staehelin: “The SIRS-Lab team is an impressive group, and I believe the SIRS-Lab technology has the potential to unlock this challenging diagnostic field by industry partnerships and with its own product pipeline.”
Nicolas Fulpius and Katrin Uschmann, Board members, comment: “We are very pleased to have recruited Mrs. Staehelin. She has unmatched experience and competences to lead an innovative company like SIRS-Lab to the next level of its development.”
Contact / Request information
Request further information free of charge:
Facts, background information, dossiers
More about SIRS-Lab
-
News
SIRS-Lab and Analytik Jena cooperate on Sepsis Diagnostics
SIRS-Lab GmbH and Analytik Jena AG will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the assoc ... more
Board elects new CEO to molecular diagnostics company SIRS-Lab GmbH
SIRS-Lab GmbH has elected Barbara Staehelin as new Chief Executive Officer. Swiss national Barbara Staehelin is a biochemist and holds an MBA from INSEAD (Fontainebleau). She is a life science entrepreneur and has also made a career in the diagnostics industry. Until 2006, she was a member ... more
-
White papers
LOOXSTER® concentrates bacterial DNA
Detection of the bacterial content of a specific sample, irrelevant from its source, is not as straightforward as it seems. In clinical microbiology laboratories, the gold standard method for the detection of pathogens in patients suspected of systemic infections is the blood culture. Howev ... more
Looxster® - Enrichment and isolation of bacterial DNA using Pureprove® Technology
Detection of the bacterial content of a specific sample, irrelevant from its source (i.e. Clinical, Food or Environmental), is not as straightforward as it seems. In clinical microbiology laboratories, the gold standard method for the detection of pathogens in patients suspected of systemic ... more
Most read news
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
News from people
News from Germany
Last viewed
- Joint research into an enzyme that causes genetic diseases -
- InProcess Instruments is now DIN EN ISO 9001:2000 certified -
- New microchip technology performs 1,000 chemical reactions at once - - Technique may accelerate drug discovery for cancer, other diseases
- Agilent Technologies to Acquire Varian, Inc. for $1.5 Billion -
- 454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright - - Sequencing Genomic Regions Associated with Psychiatric Disease
